Predisposing factors were identified in 51 patients (68.9%), including underlying cardiac conditions in 50 (67.6%). Complications occurred in 47 patients (63.5%), while 29 (39.2%) had multi-site infections. Bacterial meningitis was the most frequent manifestation of multi-site infection, affecting 16 patients (21.6%).

Pathogens were identified in 58 patients (78.4%), including S. aureus in 34 cases (45.9% of the full cohort). Compared with patients who had other culture-positive bacterial endocarditis, the S. aureus group had a shorter time to diagnosis (p = 0.008), a lower proportion with predisposing factors (p = 0.039), higher peak temperatures (p = 0.019), and higher C-reactive protein (p = 0.001) and procalcitonin (p < 0.001) levels. The S. aureus group also had higher observed rates of multi-site infection (p < 0.001), bacterial meningitis (p = 0.005), embolic events (p = 0.008), sepsis (p = 0.006), intensive care unit admission (p = 0.032) and death (p = 0.024).

These comparisons describe associations within the cohort and do not establish that S. aureus caused the more severe outcomes. Multivariable analysis identified shock and cerebral hemorrhage as independent predictors of death. The reported odds ratio was 15.294 for shock (95% confidence interval 1.196–95.559; p = 0.036) and 16.743 for cerebral hemorrhage (95% confidence interval 1.285–55.191; p = 0.031).

These estimates are imprecise, as reflected by their wide confidence intervals. The retrospective, single-center design, small sample and selected patient population limit generalizability and prevent estimation of pediatric infective endocarditis incidence across Beijing. Because the report is based only on the abstract, subgroup denominators, detailed methods and the assessment of potential confounding could not be examined.

Subject of Research: Clinical characteristics, microbiology and mortality predictors of pediatric infective endocarditis in a Beijing cohort

Article Title: Clinical characteristics of infective endocarditis in children: a single center of 10-year experience in Beijing

Article References: Xie, Y., Guo, L.-Y., Hu, B., Guo, X., Chen, T.-M., Hu, H.-L., Xiao, Y.-Y., Wang, Q., Zhen, Z., Wang, L.-J., & Liu, G. (2026). Clinical characteristics of infective endocarditis in children: a single center of 10-year experience in Beijing. BMC Pediatrics. https://doi.org/10.1186/s12887-026-07672-y

Image Credits: AI Generated

DOI: 10.1186/s12887-026-07672-y

Keywords: pediatric infective endocarditis, Staphylococcus aureus, Beijing, retrospective cohort, bacterial meningitis, cerebral hemorrhage, shock, child mortality, microbiology, single-center study, Clinical, characteristics

The authors, Harris Bendel of Roskilde University’s PandemiX Center and Katarina L. Matthes of the University of Zurich’s Institute of Evolutionary Medicine, contend that contemporary studies of measles-induced immune amnesia face structural obstacles that historical data can circumvent. In high-income countries today, measles is so rare that the few people who contract it are inherently unrepresentative of the broader population, introducing severe selection bias. In regions where measles remains common, unequal access to healthcare complicates the assembly of reliable study cohorts. Observational studies in wealthy nations are further confounded by pre-existing conditions and differences in healthcare-seeking behavior, making it difficult to isolate the virus’s effect on subsequent mortality.

These methodological problems matter because the stakes of the debate are enormous. Some researchers have suggested that measles immune amnesia may have contributed to as much as half of all childhood deaths from infectious diseases in the period before vaccination. That figure traces back to a widely cited 2015 study by Mina and colleagues, who quantified the drop in non-measles infectious disease mortality in three countries before and after measles vaccines were introduced. The commentary’s authors argue that this approach falters when applied to Denmark, one of the countries in the analysis, because the data used came from a period when infectious disease mortality had already fallen to historic lows.

The numbers illustrate the problem starkly. In 1986, the year before the measles vaccine was introduced in Denmark, there were just 19 deaths from non-measles childhood infections; five years later, in 1991, there were 16. By the 1980s, many of the most significant killers of children, from tuberculosis to diphtheria, had already been largely tamed by sanitation, antibiotics, and other vaccines. Drawing conclusions about the pre-vaccine mortality landscape from such a late period, the authors argue, is unsuitable for estimating how much measles immune amnesia contributed to childhood deaths in earlier centuries, when the infectious disease environment was fundamentally different.

The commentary also points to a mismatch between the timing of measles infections and the timing of childhood deaths in historical populations. In early twentieth-century Copenhagen, census data show that childhood mortality was heavily concentrated in the first year of life. Yet the average age of measles infection in the city between 1907 and 1930, estimated from weekly case records, was 5.65 years. If immune amnesia were a dominant driver of childhood infectious disease mortality, one would expect deaths from other infections to cluster in the years following the typical age of measles infection. Instead, the age distribution of deaths from causes such as infant diarrhea and whooping cough barely overlaps with the distribution of measles cases, making it unlikely that immune amnesia was a major contributor to infectious disease mortality in historic Copenhagen.

The authors examined an annual report on epidemic diseases from Copenhagen in 1911, which breaks down deaths by cause and age group. Of 917 total deaths recorded, infant diarrhea accounted for 309, nearly all in infants under one year, while whooping cough killed 176, again concentrated in the youngest children. Measles itself caused 40 deaths. When the researchers fitted gamma and power-law functions to the age distributions of measles infections and non-measles deaths, the resulting curves showed little overlap, mirroring patterns produced by earlier simulation studies. The authors caution that more research at the individual level is needed to fully understand immune amnesia’s role in the pre-vaccine infectious disease landscape, but the population-level patterns raise doubts about sweeping claims.

Historical data, the commentary argues, offers a unique set of advantages for studying how measles reshapes the immune system. Countries such as Denmark and Switzerland preserve individual-level mortality and morbidity records from long before the first measles vaccine was introduced, from an era when infectious disease mortality was still high. Because measles is so transmissible, infection was nearly universal among people who survived childhood, which means infected cohorts are highly representative of the general population, even though the disease’s ubiquity makes it impossible to construct a control group of unexposed individuals. Still, the timing of historical outbreaks has been well documented through demographic research, allowing study designs analogous to modern cohort studies to be reconstructed for past populations. Detailed case and hospital records in the archives can even be linked to death certificates, enabling individual-level analyses of long-term consequences.

Studying the pre-vaccine era also decouples the analysis from a separate and contested theory known as non-specific vaccine effects, which holds that live attenuated vaccines provide broad immune benefits that reduce all-cause mortality in vaccinated individuals. Although the theory is not widely accepted, it exists as an alternative explanation for the observed correlation between measles vaccination and reduced mortality. By examining the association between measles infection and non-measles mortality in periods when no measles vaccine existed, researchers can more confidently attribute any effect to the virus’s immune suppression rather than to beneficial vaccine side effects.

The commentary highlights international efforts to make such research feasible, including the COST Action known as The Great Leap, which works to make individual-level cause-specific mortality data available for historical populations and to harmonize historical causes of death across countries and time periods. Such infrastructure is important because contemporary data alone are often insufficient to understand the long-term consequences of infectious diseases. Even studies directly comparing vaccinated and unvaccinated children suffer from substantial confounding, since the two groups may differ systematically in socioeconomic status, healthcare access, health-seeking behavior, and parental attitudes toward medicine.

The authors advocate for a systematic integration of historical demographic and epidemiological data into research on the long-term consequences of infectious diseases, using measles-induced immune amnesia as a case in point. Linking individual-level historical infection records with cause-specific mortality data could overcome the limitations of modern studies and open new avenues for investigating how infections shape health long after the acute illness has passed. With recent global outbreaks suggesting that the World Health Organization’s goal of measles elimination by 2030 is unlikely to be met, and with vaccine hesitancy causing measles to reemerge in countries that had previously eliminated it, understanding the full cost of the virus has never been more urgent. Unlocking the archives, the authors conclude, may fundamentally expand our ability to grasp how infectious diseases continue to claim lives well beyond the moment of infection.

Subject of Research: The use of historical demographic and epidemiological records to study the long-term effects of measles-induced immune amnesia on childhood infectious disease mortality

Article Title: Why historical data matter for understanding the long-term effects of measles

Article References: Bendel, H., & Matthes, K. L. (2026). Why historical data matter for understanding the long-term effects of measles. International Journal of Public Health, 71, Article 1610290. https://doi.org/10.3389/ijph.2026.1610290

Image Credits: AI Generated

DOI: 10.3389/ijph.2026.1610290

Keywords: measles, immune amnesia, historical demography, historical epidemiology, child mortality, vaccination, infectious disease, Copenhagen, non-specific vaccine effects, public health, pre-vaccine era, mortality data

The study drew on the Child Health with Azithromycin Trial, known as CHAT, a placebo-controlled cluster randomized trial conducted in Burkina Faso in which entire communities were assigned, in a one-to-one ratio, to receive twice-yearly azithromycin or a matching placebo for children aged one to 59 months. The original trial was designed to test whether the antibiotic could prevent deaths from any cause, extending to a high-mortality African setting the earlier evidence from the landmark MORDOR trial in Niger, Malawi, and Tanzania, which had demonstrated a significant reduction in all-cause child mortality with mass drug administration.

The research team, led by investigators at the University of California, San Francisco and the Centre de Recherche en Santé de Nouna in Burkina Faso, asked a deceptively simple question: if azithromycin works by clearing infections, and if infections sap children’s growth, shouldn’t treated children grow better? To answer it, they tracked two standard measures of undernutrition. The first was mid-upper arm circumference, or MUAC, a tape measurement of the upper arm that is widely used in field settings to screen for acute malnutrition because it changes little with age in early childhood and requires no scales. The second was the weight-for-age Z-score, or WAZ, a statistical measure of how far a child’s weight deviates from the expected weight for a healthy child of the same age and sex, calculated here for infants aged one to eleven months.

The scale of the analysis was considerable. The researchers included 80,282 children aged one to 59 months, of whom 26,983 were infants in the one-to-eleven-month age range, drawn from 284 communities. Measurements were collected every six months over the course of the trial, with MUAC taken in all children and weight recorded in infants both to calculate weight-based drug dosing and to enable the nutritional analysis. Because communities rather than individuals were randomized, the statistical methods accounted for clustering, comparing outcomes between the azithromycin and placebo arms at the community level and also following individual children longitudinally over time.

The results were unambiguous in their null finding. At the community level, after 36 months of intervention there was no evidence of any difference in mean MUAC or mean WAZ between villages that had received azithromycin and those that had received placebo. Nor was there any divergence over time: the change in MUAC over the follow-up period showed no difference between arms, with a P-value for interaction of 0.94, and the change in WAZ similarly showed no difference, with a P-value of 0.18. In plain terms, children in azithromycin communities did not have measurably better arm circumference or weight gain than children in placebo communities, either on average or in their growth trajectories.

These findings matter because they speak directly to the leading hypothesis about how mass azithromycin saves lives. The drug, a long-acting macrolide antibiotic, is known to treat a broad range of bacterial infections and some intracellular pathogens, including subclinical infections that never announce themselves with fever or clinic visits. Researchers have plausibly argued that reducing this invisible infectious burden could free up calories and nutrients that would otherwise be diverted to immune defense, allowing children to grow better and thereby lowering their vulnerability to severe illness and death. Undernutrition and infection form a well-documented vicious cycle in early childhood: infection suppresses appetite and impairs nutrient absorption, while malnutrition weakens immune defenses and increases the severity of subsequent infections. Breaking that cycle at the infection end, the reasoning went, should improve the nutrition end.

The CHAT nutritional analysis suggests it did not, at least not in this setting. One interpretation is that the infections most responsible for azithromycin’s mortality benefit are acute, severe episodes rather than the chronic, growth-slowing burden that shapes anthropometric measures over months and years. Mortality in these settings is often driven by rapidly progressive infections such as pneumonia, sepsis, and malaria-associated bacterial coinfections, which can kill a child long before any nutritional pathway could come into play. If azithromycin primarily prevents these fulminant events, its effect on growth would be expected to be small or absent, exactly what the trial observed.

Another possibility is that the dominant drivers of undernutrition in Burkina Faso lie outside the reach of a twice-yearly antibiotic. Diarrheal disease from enteric pathogens, environmental enteric dysfunction driven by repeated exposure to fecal contamination, dietary insufficiency, and malaria are all entrenched in the region, and a macrolide given twice a year may not durably suppress the microbial ecology that stunts growth. Some of the pathogens that most strongly depress growth, such as certain enteroviruses and parasites, are not susceptible to azithromycin at all. The drug’s effects on the gut microbiome, moreover, are complex, and repeated exposure has been associated with rising antimicrobial resistance, a concern that weighs on any expansion of mass distribution programs.

For policymakers, the analysis does not undermine the case for mass azithromycin where mortality benefits have been demonstrated, but it does sharpen the picture of what the intervention can and cannot do. Countries weighing twice-yearly distribution should not expect it to serve as a nutrition program, and investments in the established tools of nutrition improvement, including infant and young child feeding, micronutrient supplementation, food security, and water, sanitation, and hygiene infrastructure, remain essential alongside any antibiotic strategy. The finding also redirects scientific attention toward identifying the actual biological mechanisms behind the mortality reduction, whether through targeted studies of severe infection incidence, biomarkers of systemic inflammation, or cause-of-death ascertainment in future trials.

The study also illustrates the value of embedding mechanistic questions within large mortality trials. Because CHAT already collected MUAC and weight measurements at six-month intervals across nearly three hundred communities, the researchers could test the nutritional hypothesis with statistical power that no standalone study of this size could easily achieve, while respecting the cluster randomized design that guards against contamination between intervention and comparison groups. The trial was registered as NCT03676764 on ClinicalTrials.gov, and the analysis protocol was specified in advance as a secondary objective, reducing the risk of post hoc interpretation. As mass azithromycin programs move from trials toward policy in high-mortality settings, studies like this one will be essential for calibrating expectations, ensuring that a genuinely promising mortality intervention is deployed for what it does, and not credited with benefits the evidence does not support.

Subject of Research: Effects of twice-yearly mass azithromycin distribution on nutritional status in young children

Article Title: Mass azithromycin distribution and nutritional status among children aged 1–59 months: A secondary analysis of a cluster randomized trial

Article References: Ouattara, M., Hu, H., Bountogo, M., Coulibaly, B., Boudo, V., Compaoré, G., Dah, C., Lebas, E., O’Brien, K. S., Arnold, B. F., Lietman, T. M., Sié, A., & Oldenburg, C. E. (2026). Mass azithromycin distribution and nutritional status among children aged 1–59 months: A secondary analysis of a cluster randomized trial. PLOS Global Public Health, 6(10), e0007473. https://doi.org/10.1371/journal.pgph.0007473

Image Credits: AI Generated

DOI: 10.1371/journal.pgph.0007473

Keywords: azithromycin, child mortality, malnutrition, MUAC, weight-for-age Z-score, Burkina Faso, cluster randomized trial, mass drug administration, global health, undernutrition, CHAT trial, PLOS Global Public Health

The study enrolled children aged one month to twelve years who arrived at the hospital with features of suspected infection, a deliberately broad entry criterion designed to capture the full spectrum of illness that pediatric wards in the region actually face. Rather than relying on older, contested sepsis definitions, the team applied the Phoenix Sepsis Score, a modern scoring system developed through international consensus that assigns points across four organ systems: cardiovascular, respiratory, neurological and coagulation. A child was classified as having septic shock when suspected infection coincided with a Phoenix score above two points and at least one point in the cardiovascular domain, reflecting the circulatory collapse that defines shock. This approach matters because pediatric sepsis has long suffered from inconsistent definitions, making it difficult to compare findings across hospitals, countries and continents.

The cross-sequential design allowed the researchers to assess children at admission and then follow them through their hospital stay until discharge, linking baseline clinical characteristics to downstream outcomes. Of the 422 children included in the analysis, 175 developed or presented with septic shock by the study criteria. That prevalence, more than four in every ten children admitted with suspected infection, is striking when set against figures from high-income settings, where septic shock among hospitalized children with infection is typically far less frequent. The difference reflects a convergence of factors: delayed presentation to health facilities, limited access to intensive care, high background rates of malaria and malnutrition, and referral systems that often deliver the sickest children to regional hospitals only after their condition has deteriorated.

Indeed, referral status emerged as the single strongest independent predictor of septic shock in the study. Children who had been referred from lower-level health facilities were nearly three times more likely to have septic shock than those who arrived directly, with an adjusted odds ratio of 2.895. This finding carries a clear operational message: the journey through Uganda’s tiered health system, from village clinics to health centers to regional referral hospitals, appears to consume precious time during which an infection can progress from manageable to life-threatening. Each intermediate stop introduces delays in antibiotics, fluids and other interventions that are most effective when delivered early in the course of illness.

Malaria also doubled the risk, with children carrying the parasite showing an adjusted odds ratio of 2.072 for septic shock. This is biologically plausible and clinically important in a region where malaria transmission is intense and seasonal. Severe malaria itself can precipitate cardiovascular collapse, and the overlap between malaria and bacterial sepsis complicates diagnosis, since fever, anemia and altered consciousness are common to both. The finding suggests that children with malaria who show any signs of circulatory compromise warrant close monitoring for septic shock rather than being managed as routine malaria cases alone.

Nutrition emerged as another powerful modifiable factor. Severe acute malnutrition, a condition affecting millions of children across sub-Saharan Africa, nearly tripled the odds of septic shock, with an adjusted odds ratio of 2.638. Malnourished children have impaired immune function, compromised gut barriers that allow bacteria to translocate into the bloodstream, and reduced physiological reserves to withstand the metabolic demands of a systemic infection. The study also found that abnormalities in circulating blood cells were independently associated with shock: neutrophilia, an elevated count of the white blood cells that form the first line of antibacterial defense, raised the odds by more than twofold, while anemia showed a dose-response relationship. Moderate anemia increased the odds by 2.346 times and severe anemia by 3.339 times, indicating that the more profound the reduction in oxygen-carrying capacity, the greater the risk of circulatory failure.

The consequences of septic shock in this cohort were severe and measurable. Mortality among children with septic shock reached 9.1 percent, while not a single child without sepsis died during the study period, a difference the authors report as highly significant. Put another way, every death recorded in the study occurred among children whose infection had progressed to shock. In addition, children with septic shock were more than twice as likely to experience prolonged hospital stays, 17.6 percent compared with 7.5 percent among those without sepsis. Prolonged hospitalization is not merely an inconvenience; it occupies scarce pediatric beds, increases the risk of hospital-acquired infections, imposes financial strain on families who often travel long distances and pay out of pocket for care, and delays the return of surviving children to their communities and schools.

The authors frame their findings around a set of actionable targets, several of which are modifiable at the population level. Screening for malnutrition and anemia, treating malaria promptly and effectively, and educating caregivers about early warning signs that should trigger immediate care-seeking could, the study suggests, meaningfully reduce the burden of septic shock before children ever reach the hospital. The referral pathway finding points to a complementary strategy at the system level: strengthening the capacity of peripheral health facilities to initiate resuscitation and antibiotics, and improving the speed and safety of transfers, could shorten the window during which children deteriorate en route to definitive care.

The study also demonstrates the practical value of the Phoenix Sepsis Score in settings far from the intensive care units where such tools are usually validated. Because the score relies on bedside observations and basic laboratory values rather than expensive imaging or specialized monitoring, it can be applied in district and regional hospitals across Africa, giving clinicians a standardized way to identify the children at highest risk. Standardized identification is the first step toward standardized treatment, and toward generating comparable data that can drive regional and national policy on pediatric sepsis.

For a condition that remains one of the leading contributors to child mortality in Uganda, this research provides both an alarm and a roadmap. The alarm is the sheer scale of the problem: septic shock is not a rare complication on these wards but a routine reality affecting more than forty percent of children admitted with suspected infections. The roadmap lies in the five independent risk factors the study identified, most of which are detectable at the bedside and several of which are preventable through interventions that already exist in the Ugandan health system. Closing the gap between what is known and what is delivered, from iron supplementation and nutrition programs to faster referrals and earlier antibiotics, may prove to be the most effective way to keep children with infections from ever crossing the threshold into shock.

Subject of Research: Prevalence, risk factors and outcomes of septic shock among children with suspected infection in rural Uganda

Article Title: Prevalence, associated factors and outcomes of septic shock among children with suspected infection in rural Uganda: a cross-sequential study

Article References: Bizimana, G. N., Elfakey, W., Justin, O. R., Mambo, S. B., Muhumuza, J., & Nduwimana, M. (2026). Prevalence, associated factors and outcomes of septic shock among children with suspected infection in rural Uganda: a cross-sequential study. BMC Pediatrics. https://doi.org/10.1186/s12887-026-07736-z

Image Credits: AI Generated

DOI: 10.1186/s12887-026-07736-z

Keywords: septic shock, sepsis, pediatrics, Uganda, malaria, malnutrition, anemia, Phoenix Sepsis Score, child mortality, referral systems, hospital outcomes, resource-limited settings

The study’s central conclusion is stark: the majority of hospitalisations and deaths among children in their first two years of life are caused by infectious diseases that are, in principle, preventable. Malaria alone accounted for 54.3 percent of all hospital admissions recorded during the follow-up period, dwarfing every other cause of severe illness. Lower respiratory infections ranked second at 16.7 percent of admissions, followed by diarrhoeal disease at 9.6 percent, undernutrition at 7.4 percent and sepsis at 4.8 percent. Among deaths that occurred in hospitals with available medical records, malaria was responsible for 50.6 percent, meaning that one in every two in-hospital deaths in this age group was attributable to a single parasitic disease transmitted by mosquitoes.

The burden extends beyond hospital walls. For children who died outside medical facilities, the research team reconstructed probable causes of death through standardised interviews with family members and caregivers, a well-established epidemiological technique known as verbal autopsy. This analysis likewise identified malaria as the most frequent cause of death, followed by respiratory infections and diarrhoea. The researchers caution, however, that verbal autopsy is likely to underestimate malaria mortality, because the fever and generalised symptoms characteristic of severe malaria overlap considerably with those of other common infectious diseases, making it difficult for bereaved caregivers to distinguish between them when recalling a child’s final illness.

The scale and precision of the study distinguish it from previous efforts to characterise early childhood disease burden in the region. Routine surveillance systems in Sierra Leone and many other countries typically group all children under five into a single reporting category, a practice that obscures the distinct epidemiology of infancy and early toddlerhood and makes it difficult to identify precisely which conditions drive hospitalisation and death at different ages. To close this gap, the ICARIA team combined continuous health facility surveillance with household visits, telephone follow-up and a network of community informants, creating an unusually complete record of both severe illness and mortality across the first two years of life.

“To address this important knowledge gap, we followed 20,560 infants up to 24 months of age across 14 health centres in three districts of Sierra Leone,” explained Kwabena Owusu-Kyei, an ISGlobal researcher based in Sierra Leone and first author of the study. “By combining health facility surveillance with household visits, telephone follow-up and community informants, we were able to build a much more complete picture of childhood hospitalisations and deaths.” During the follow-up period, the cohort recorded 2,688 hospital admissions and 859 deaths, figures that translate into an extraordinary concentration of severe disease in a population of children who had, by the study’s design, access to facilities offering free healthcare.

The context of Sierra Leone’s public health landscape makes the findings all the more consequential. Over the past decade and a half, the country has introduced a series of major initiatives aimed at reducing child deaths, including a policy of free healthcare for children under five, malaria chemoprevention programmes, pneumococcal vaccination and, more recently, the rollout of the malaria vaccine. Yet until now, it has been difficult to assess how these interventions are affecting survival during the first two years of life, the period when children are most vulnerable to the infectious diseases that dominate the region’s disease burden. The new study provides the granular evidence base that such assessments require.

Beyond quantifying the burden of disease, the study identified several factors strongly associated with a child’s chances of survival, offering concrete targets for intervention. Children who had received all the routine vaccines of the Expanded Programme on Immunization (EPI) due for their age had a 35 percent lower risk of overall mortality compared with incompletely vaccinated children. Complete vaccination was also associated with a 29 percent lower likelihood of dying during a hospital admission and, strikingly, a 44 percent lower risk of death in the period after discharge from hospital, a finding that underscores how vaccination status shapes resilience well beyond the immediate protection conferred against specific vaccine-preventable pathogens.

Malaria chemoprevention also emerged as a powerful protective factor. Children who received all scheduled doses of sulfadoxine–pyrimethamine, the preventive antimalarial treatment delivered through Sierra Leone’s immunisation programme, had a 40 percent reduction in mortality risk compared with those who missed doses. Conversely, undernutrition significantly increased the risk of dying during hospitalisation, a result that reinforces long-standing calls to integrate nutritional support into paediatric care rather than treating malnutrition and infectious disease as separate clinical problems. Taken together, these associations suggest that the tools needed to save young lives largely already exist within the health system, but that coverage, adherence and integration remain insufficient.

The study arrives at a moment of broader concern for global child health. Worldwide, child mortality has declined substantially over recent decades, one of the great public health achievements of the modern era, but the progress achieved up to 2015 has since stalled. In many countries across sub-Saharan Africa, infectious diseases remain among the greatest threats to survival during the first years of life, and the stagnation of mortality declines suggests that existing strategies are not reaching their full potential. Sierra Leone, still rebuilding its health system after decades of civil war and the 2014 Ebola epidemic, exemplifies the challenge facing the world’s most vulnerable settings.

“These findings show that there is still a substantial unfinished agenda in global health, and that strengthening vaccination, malaria prevention, community-based care and post-discharge follow-up are essential to reducing child mortality in the world’s most vulnerable settings and meeting the Sustainable Development Goals,” concluded Clara Menéndez, Director of ISGlobal’s Maternal, Child and Reproductive Health Programme and principal investigator of the study. With the Sustainable Development Goal target of ending preventable deaths of newborns and children under five by 2030 drawing closer, the Sierra Leone cohort offers both a warning and a roadmap: the diseases killing the youngest children are known, the preventive tools are available, and the decisive variable is whether they reach every child who needs them.

Subject of Research: Causes of hospitalisation and death from malaria and other infectious diseases in children under two in Sierra Leone

Article Title: Malaria remains the leading cause of hospital admission and in-hospital death in children under two in Sierra Leone

Article References: Malaria remains the leading cause of hospital admission and in-hospital death in children under two in Sierra Leone. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: malaria, child mortality, Sierra Leone, The Lancet Global Health, ISGlobal, ICARIA project, vaccination, chemoprevention, sulfadoxine-pyrimethamine, undernutrition, respiratory infections, verbal autopsy

A new study from Nouna District in rural Burkina Faso set out to answer that question with unusual methodological rigor. Published in PLOS One, the research was led by Huiyu Hu of the University of California, San Francisco, together with colleagues including Catherine E. Oldenburg and investigators from the Centre de Recherche en Santé de Nouna in Burkina Faso. Rather than simply comparing children who were referred with those who were not, the team used a prospective regression discontinuity design, an approach borrowed from economics and epidemiology that exploits the arbitrary nature of a treatment cutoff to estimate causal effects near the threshold itself.

The logic of a regression discontinuity design is elegant. Children whose MUAC falls just below 11.5 centimeters are recommended for referral, while children measuring just above it are not. Because arm circumference varies continuously, children at 11.4 and 11.6 centimeters are, on average, nearly identical in every other respect. Any sharp difference in their later outcomes can therefore be attributed to the eligibility rule itself rather than to underlying differences in health status. This makes the design far less vulnerable to the confounding that plagues ordinary observational comparisons, in which sicker children are naturally more likely to be referred.

The analysis was nested within the Community Health with Azithromycin Treatment trial, a cluster-randomized controlled trial registered as NCT03676764. As part of that trial, children aged 6 to 59 months in Nouna District were screened during twice-yearly censuses, with MUAC measured at each encounter. A reading below 11.5 centimeters triggered a recommendation that the child be referred to a nutritional program. Crucially, the researchers could not measure whether referred children actually enrolled in treatment, so the study estimated the effect of referral eligibility rather than of treatment receipt itself. This distinction, known as an intention-to-treat framing, reflects the reality of many health systems, where a referral slip is only the first step in a long chain of care.

The scale of the screening effort was enormous. Among 65,554 children measured across the study, only 226, or roughly one in three hundred, met the referral threshold at least once. That low prevalence underscores both the rarity of severe acute malnutrition in this population at the time of screening and the logistical challenge of studying it: even a census covering tens of thousands of children yields only a few hundred children near the cutoff. The researchers therefore concentrated their analysis on observations close to the 11.5-centimeter boundary, using outcome-specific bandwidth selection following the Imbens-Kalyanaraman approach to decide how wide a window around the cutoff to include.

For the anthropometric outcome, the selected bandwidth contained 2,901 observations, of which 158 fell below the cutoff and 2,743 above it. For mortality, the window included 2,628 observations, with 148 below and 2,480 above the threshold. The team fitted mixed-effects models with a random intercept for each child, accounting for the fact that the same children contributed repeated measurements across census rounds. The primary outcomes were MUAC at the next census and death from any cause before that census, providing a standardized follow-up window anchored to the routine measurement schedule.

The results were strikingly null. At the cutoff, children eligible for referral had a mean MUAC at the next census just 0.21 centimeters greater than children just above the threshold, with a 95 percent confidence interval stretching from minus 0.22 to 0.65 centimeters, a range that comfortably includes no effect. For mortality, the estimated odds ratio was 0.95, with a confidence interval from 0.03 to 31.37. That interval is so extraordinarily wide that it technically spans everything from a nearly complete protective effect to a more than thirtyfold increase in risk, a consequence of the small number of deaths near the cutoff. The authors were careful to emphasize this imprecision rather than overstate the reassurance that a point estimate near one might suggest.

Most sensitivity analyses produced similar findings, lending some stability to the central conclusion. The exception was instructive: when the researchers imposed the widest fixed bandwidth, the estimates became discordant and unstable, a reminder that regression discontinuity results depend on how far from the cutoff one is willing to extrapolate. Far from the threshold, children differ in ways that the design can no longer balance, and the local causal interpretation dissolves. The narrow, honest answer this study provides applies to children hovering near 11.5 centimeters, not to all children with malnutrition.

What, then, explains the absence of an effect? The authors point to a gap that the study was never designed to close but that its framing illuminates. Referral eligibility is not treatment. A recommendation to seek care must survive the journey to a health facility, the availability of ready-to-use therapeutic foods, stock-outs, costs, and caregiver decisions before it becomes actual treatment. If few children near the cutoff ultimately completed referral and received therapy, an intention-to-treat estimate near zero is exactly what one would expect, even if the treatment itself works well. The study, by its own account, does not evaluate whether SAM treatment is effective, only whether the screening-and-referral machinery as it operated in Nouna moved the needle on child outcomes.

The implications reach well beyond Burkina Faso. MUAC-based screening is a cornerstone of community case finding for severe acute malnutrition across the Sahel and beyond, and the 11.5-centimeter cutoff is an international standard. This study does not challenge the cutoff’s ability to identify high-risk children, but it does raise a pointed question about what happens after identification. If crossing the threshold does not reliably translate into improved nutritional status or survival, the bottleneck may lie downstream, in the strength of the referral chain and the capacity of treatment programs. As the authors conclude, stronger mechanisms may be needed to complete referrals and link children to care. For a global health community investing heavily in community screening, the message is sobering and constructive at once: finding the children is only half the task, and the half that follows may determine whether the tape measure saves lives.

Subject of Research: Effect of referral eligibility based on mid-upper arm circumference screening for severe acute malnutrition on child nutritional status and mortality in Burkina Faso

Article Title: Effect of eligibility for referral following mass screening for severe acute malnutrition using mid-upper arm circumference: A prospective regression discontinuity design

Article References: Hu, H., Ouattara, M., Bountogo, M., Boudo, V., Ouedraogo, T., Dah, C., Lebas, E., Bärnighausen, T., Arnold, B. F., O’Brien, K. S., Lietman, T. M., Sié, A., & Oldenburg, C. E. (2026). Effect of eligibility for referral following mass screening for severe acute malnutrition using mid-upper arm circumference: A prospective regression discontinuity design. PLOS One, 21(10), e0359729. https://doi.org/10.1371/journal.pone.0359729

Image Credits: AI Generated

DOI: 10.1371/journal.pone.0359729

Keywords: severe acute malnutrition, mid-upper arm circumference, MUAC, regression discontinuity, Burkina Faso, child mortality, referral eligibility, community screening, nutritional programs, global health, PLOS One, intention-to-treat

The scale of the dataset is what gives the findings their power. Rather than relying on a single city or a sample of hospital admissions, the team analyzed the full national corpus of police-reported crashes involving child pedestrians over three consecutive years. Out of those 31,499 records, 507 were linked to crashes in which at least one person died within 30 days, and 420 records represented children who themselves died within 30 days of the collision. That distinction matters more than it might first appear. A crash that kills someone is not necessarily a crash that kills the child pedestrian in the record; the victim could be a driver, a passenger, or another road user. By modeling both outcomes separately, the researchers could ask two complementary questions: what makes a crash severe, and what makes a particular child’s own outcome fatal?

The answer to both questions points, above all, to heavy vehicles. When the researchers ran prespecified multivariable logistic regressions adjusting for other factors, involvement of a heavy vehicle was associated with an odds ratio of 8.25 for fatal-crash involvement, with a 95 percent confidence interval of 5.45 to 12.48. In the child-mortality model, the corresponding odds ratio was 7.14. In plain terms, a child pedestrian struck in a crash involving a heavy vehicle was roughly seven to eight times more likely to be part of a deadly event than a child in a comparable crash without one. The physics is unforgiving: a large truck or heavy goods vehicle carries enormous kinetic energy at ordinary speeds, its front geometry tends to strike a child’s head and torso rather than legs, and its elevated cab can push a small body under the wheels rather than over the hood.

Speed-related driver fault, as coded by police, was the second dominant signal. Crashes in which officers attributed speed-related fault to a driver carried an odds ratio of 3.56 for fatal-crash involvement and 3.32 for the child’s own 30-day mortality. The confidence intervals, ranging from roughly 2.9 to 4.4, indicate a robust and consistent association across both outcome definitions. This aligns with decades of biomechanical research showing that the probability of a pedestrian’s death rises steeply with impact velocity. At 30 kilometers per hour, an adult pedestrian’s chance of dying is low; by 80 kilometers per hour, it approaches certainty. Children are more vulnerable still, because their shorter stature places their center of mass below typical hood lines and their smaller bodies absorb proportionally more energy per kilogram of tissue.

Road hierarchy emerged as a third pillar of risk. Crashes on major or higher-order roads were associated with an odds ratio of 3.60 for fatal-crash involvement and 3.52 for child mortality, while buses and minibuses carried an odds ratio of 3.09 in the fatal-crash model. Locations outside built-up areas doubled the odds of fatal-crash involvement, at 2.25, and nighttime conditions raised them by roughly 90 percent, at 1.90. Each of these factors tells a coherent story about exposure and energy. Major roads carry faster traffic and mix pedestrians with high-speed flows; rural and out-of-town settings combine higher speeds with longer emergency response times and less lighting; darkness reduces both driver detection distance and a child’s ability to judge approaching vehicles.

What makes the study methodologically interesting is the near-concordance between the two models. The fatal-crash involvement model, which captures the severity context of the entire collision, and the child-mortality model, which isolates the recorded child’s own outcome, produced broadly similar patterns across vehicle type, road class, speed fault, location and lighting. This consistency suggests that the same system-level conditions that make crashes severe in general are the ones that kill child pedestrians specifically. It also strengthens the case that the findings are not artifacts of a particular outcome definition or coding quirk. The researchers performed sensitivity analyses using alternative model specifications, and the core associations held.

The authors are careful, and rightly so, about what the numbers cannot say. Police-coded driver fault variables, including the speed-fault category, are recorded by officers at the scene and reflect administrative judgment as much as physical measurement. A police attribution of speed fault may correlate with actual impact speed, but it may also correlate with other unmeasured features of the crash, the driver, or the investigation itself. The study is retrospective and observational, so causal interpretation should be avoided, particularly for the fault variables. A heavy vehicle’s presence in a fatal crash, for instance, may partly reflect the routes such vehicles travel and the exposure of children along those routes, not only the vehicle’s destructive potential in a given impact.

Even with those caveats, the policy implications are hard to ignore, because they map directly onto the Safe System approach that the World Health Organization promotes and that Sweden pioneered under the name Vision Zero. Safe System thinking holds that road deaths are not primarily the product of individual carelessness but of a transport system that permits human error to coincide with lethal energy. The Turkish findings identify precisely where that coincidence occurs for children: where heavy vehicles and buses share space with young pedestrians, where major roads lack protected crossings, where speeds exceed survivable impact thresholds, and where darkness strips away the margins of perception. Countermeasures follow naturally. Lower speed limits around schools and residential zones, physically separated crossings on arterial roads, side-underrun guards and improved direct vision on trucks, lighting upgrades at known crossing points, and routing of heavy traffic away from child-dense corridors all address the specific risk factors the data isolate.

The study also fills an important gap in the global evidence base. Most detailed pedestrian fatality analyses come from high-income countries with mature data systems, yet the burden of child road deaths falls disproportionately on low- and middle-income countries. Türkiye’s national police crash registry, covering three years and more than thirty thousand child pedestrian records, demonstrates that administrative data collected for enforcement purposes can be repurposed for rigorous epidemiology. The researchers received the de-identified records under official institutional permission, no personal identifiers were involved, and no external funding supported the work. The team, led by Seda Hatipoğlu of Gazi University’s Department of Traffic Planning and Implementation, together with Tuğba Soy of the Turkish National Police and Ömer Asal of Gazi University’s Department of Manufacturing Engineering, spans the disciplines the problem demands: traffic engineering, enforcement data, and engineering analysis.

For the families behind the 420 child deaths in the dataset, the statistics will offer no comfort. But for the engineers, planners and policymakers responsible for the next decade of road design, the message is unusually clear and unusually well quantified. A child walking home at night, on a major road, outside a built-up area, in the path of a speeding truck, faces odds measured in multiples, not percentages, of a fatal outcome. Every one of those conditions is a design choice that a society has made and can remake. The study does not prove that changing any single factor will save a specific child’s life, but it shows with national-scale precision where the lethal energy in the system concentrates, and that is exactly where prevention should begin.

Subject of Research: System-level risk factors for fatal crashes and 30-day mortality among child pedestrians in Türkiye

Article Title: System-level factors associated with fatal-crash involvement and 30-day mortality among child pedestrians in Türkiye: a national retrospective study

Article References: Hatipoğlu, S., Soy, T., & Asal, Ö. (2026). System-level factors associated with fatal-crash involvement and 30-day mortality among child pedestrians in Türkiye: a national retrospective study. BMC Pediatrics. https://doi.org/10.1186/s12887-026-07827-x

Image Credits: AI Generated

DOI: 10.1186/s12887-026-07827-x

Keywords: child pedestrian safety, road traffic crashes, fatal-crash involvement, child mortality, heavy vehicles, speeding, Safe System, injury epidemiology, logistic regression, administrative crash records, Türkiye, road safety policy

The scale of the data collection alone makes the study remarkable. The research team, led by Brhane Ayele of the Tigray Health Research Institute together with colleagues from Mekelle University, the Tigray Regional Health Bureau, and the University of South Carolina, analyzed records for 30,935 live births. The first eighteen months of life is widely recognized as a critical period for long-term survival, yet robust evidence on mortality during this window in conflict-affected settings has been persistently scarce. Health systems in Tigray collapsed under the strain of fighting that began in November 2020, leaving clinics nonfunctional, supply chains severed, and families displaced into camps or hiding. Against that backdrop, the study provides something rare: a statistically rigorous, population-wide measurement of what happened to children born into catastrophe.

The headline number is stark. Of the 30,935 live births tracked, 1,430 children died before turning one and a half years old, a mortality proportion of 4.6 percent with a 95 percent confidence interval of 4.4 to 4.9 percent. Even more striking is the timing of those deaths: three-quarters occurred during the neonatal period, the first four weeks of life. This concentration in the earliest days points directly to the machinery of safe childbirth as the broken link. When hospitals and health centers close, when skilled birth attendants disappear, and when roads become impassable, the moment of delivery itself becomes the deadliest passage a child faces. The mean survival time among the cohort was 524.69 days, with a confidence interval of 523.41 to 525.97 days, a figure that conceals the sharp clustering of deaths in the opening weeks.

To understand which children were most at risk, the researchers deployed the standard analytical toolkit of survival analysis. Kaplan-Meier curves were used to estimate survival probabilities over time, while log-rank tests compared differences between groups defined by maternal, household, and geographic characteristics. The team then fitted a Cox proportional hazards model, the workhorse of epidemiological time-to-event analysis, to estimate adjusted hazard ratios for each potential predictor while controlling for the others. A hazard ratio above one indicates elevated risk of death at any given moment; the study declared statistical significance at a p-value below 0.05, and all analyses were performed in SPSS. This layered approach separates genuine risk factors from mere correlations, and the results are sobering in their clarity.

The single most dramatic predictor was where and how a child was born. Babies delivered at internally displaced persons camps or on the way to a health facility faced a 4.27-fold higher hazard of death compared with those born in safer conditions, with a confidence interval of 3.08 to 5.92. Children born in the bush, away from any medical infrastructure, carried a 1.74-fold higher hazard, ranging from 1.36 to 2.23. These numbers translate an abstract statistic into a concrete picture: a mother in labor fleeing her home, delivering in a tent or a field, without sterile equipment, emergency obstetric care, or neonatal resuscitation, faces odds that her child will not survive that are several times worse than a facility birth would have offered. The finding underscores that the collapse of institutional delivery services was not a peripheral casualty of the war but a central driver of infant death.

Reproductive and household characteristics also carried enormous weight. Multiple pregnancies, meaning twins or higher-order births, were associated with a 4.91-fold increase in the hazard of death, with a confidence interval of 4.02 to 6.00, reflecting the intrinsic biological vulnerability of multiple births compounded by the absence of specialized neonatal care. Short birth intervals, the spacing of pregnancies too closely together, emerged as the strongest single predictor in the entire model, raising the hazard of death by 6.96 times, with a confidence interval of 5.89 to 8.24. This finding aligns with decades of demographic research showing that depleted maternal recovery time between pregnancies compromises both fetal development and newborn resilience. In a war zone where contraception and family planning services evaporated, the biological consequences of uncontrolled fertility were amplified into a lethal risk multiplier.

Geography and social structure left their own fingerprints on the survival curves. Children living in rural areas faced a 1.37-fold higher hazard of death than their urban counterparts, with a confidence interval of 1.16 to 1.62, a gap that reflects both the greater destruction of rural health infrastructure and the longer distances to any functioning care. Districts classified as having an extremely very high level of maternal mortality transition showed a 1.33-fold elevated hazard, from 1.04 to 1.70, indicating that the places where mothers were dying in greatest numbers were also the places where their babies were most likely to die. Residence outside Mekelle, the regional capital, was independently associated with higher mortality, as was male infant sex and membership in smaller families, the latter possibly reflecting reduced household support networks and caregiving capacity during displacement and scarcity.

The methodological foundation of the study deserves attention because it determines how much weight the findings can bear. As a retrospective cohort built on a large community-based survey of under-five mortality, the study captured births and deaths reported by household members rather than relying on hospital records that would have missed the vast majority of deliveries occurring outside facilities. Ethical clearance was obtained from the Mekelle University College of Health Sciences Research and Community Service ethical review board, and informed verbal consent was collected from participants, with adult household caregivers responding when mothers were absent. The primary survey received partial funding from UNICEF and UNFPA, though the funders played no role in data collection, analysis, or interpretation. The breadth of coverage, spanning 121 tabiyas across 31 districts, gives the estimates a population-level authority that smaller facility-based studies in conflict zones have lacked.

The authors frame their conclusions as a call to immediate, targeted action rather than a lament. Their recommendations include expanding community-based delivery services so that skilled care reaches women where they are, strengthening referral systems to move obstetric emergencies to functioning facilities, and promoting safe facility-based births through maternity waiting homes and transport support for mothers in remote areas. They further argue that conflict-sensitive health planning should be institutionalized, with equity-driven resource allocation that prioritizes rural and conflict-affected districts rather than defaulting to urban centers. Integrating culturally appropriate family planning services addresses the short birth interval finding directly, while establishing robust mortality surveillance systems would ensure that future crises are measured in real time rather than reconstructed afterward.

Beyond its immediate regional significance, the study contributes to a growing scientific literature on how armed conflict reshapes demographic risk. The concentration of deaths in the neonatal period, the outsized hazards attached to place of birth, and the powerful effect of birth spacing together sketch a coherent causal architecture: war kills newborns primarily by destroying the systems that make childbirth safe. For humanitarian agencies, the message is that neonatal survival in conflict settings is not primarily a nutrition problem or a vaccination problem, at least not in the first weeks of life, but an obstetric access problem. For epidemiologists, the demonstration that a Cox proportional hazards framework can extract actionable risk profiles from community survey data in a war zone offers a template for future studies in Ukraine, Sudan, Gaza, and other theaters where children are being born into violence. The 1,430 children whose deaths anchor this analysis represent a measured, verifiable accounting of loss, and the predictors identified give the region, and the world, a precise map of where to intervene first when the next crisis comes.

Subject of Research: Child survival and predictors of time-to-death among live births during the Tigray war in Ethiopia

Article Title: Survival status and predictors of time-to-death among live-birth children during war time in Tigray: A retrospective cohort study

Article References: Ayele, B., Teka, H., Legesse, A. Y., Tsadik, M., Gebrekurstos, G., Abraha, H. E., Berhe, B., Fisseha, G., Ebrahim, M. M., Hailu, A. G., Gebremeskel, T., Gebremariam, T., Hadush, M. Y., Hagos, T., Muez, K., Tsegay, H., Mulugeta, A., & Godefay, H. (2026). Survival status and predictors of time-to-death among live-birth children during war time in Tigray: A retrospective cohort study. BMC Pediatrics. https://doi.org/10.1186/s12887-026-07797-0

Image Credits: AI Generated

DOI: 10.1186/s12887-026-07797-0

Keywords: child mortality, Tigray war, Ethiopia, neonatal mortality, survival analysis, Cox proportional hazards, retrospective cohort, maternal health, conflict health, birth interval, internally displaced persons, BMC Pediatrics

The research team, led by Maureen Moyo-Chilufya of Stellenbosch University together with colleagues at the London School of Hygiene & Tropical Medicine, searched five major databases—Embase, Global Health, MEDLINE, PubMed and PsycInfo—and screened 12,664 records to arrive at their final set of studies. To be included, studies had to compare mortality between children aged 0 to 19 with and without disabilities, apply a clear definition of disability, and report mortality data separately for young people rather than folding them into adult figures. Sixteen of the 29 studies provided sufficiently adjusted estimates for the pooled meta-analysis, contributing 26 comparative analyses.

The headline number conceals striking variation by age. Among children aged 0 to 5 years, the mortality gap was widest: those with disabilities died at 7.51 times the rate of their non-disabled peers. For older children and adolescents aged 6 to 19, the ratio was 4.68. The elevated risk in the earliest years of life points to a critical window, the authors suggest, where early identification, family-centred support and access to primary healthcare could make the greatest difference to survival.

Even more dramatic differences emerged when the researchers broke the results down by type of impairment. Children with neurological disabilities—conditions such as cerebral palsy and congenital Zika virus syndrome—experienced an 11.71-fold higher mortality, the largest disparity of any category examined. Those with intellectual and developmental disabilities, including autism, attention deficit hyperactivity disorder and Down syndrome, faced a 4.45-fold higher risk. By contrast, the analysis found no statistically significant difference in mortality for children with physical impairments such as achondroplasia and osteogenesis imperfecta, although the authors caution that only a small number of comparison groups were available in that category, limiting the precision of the estimate.

Statistically, the synthesis was far from straightforward. The studies displayed very high heterogeneity—an I-squared statistic of 98 percent in the overall pooled estimate—reflecting wide variation in how disability was defined, how mortality was ascertained, and which confounding factors were adjusted for. The researchers used random-effects models on the logarithmic scale, applied the DerSimonian and Laird method for estimating between-study variance, and conducted subgroup analyses by age and impairment type to probe the sources of that variability. Sensitivity analyses restricted to a single estimate per study, and separate pools for age-sex-adjusted versus multivariable-adjusted estimates, both confirmed that the direction and magnitude of the association held firm.

The team also checked for publication bias, the tendency for studies with dramatic findings to be published more readily than null results. Visual inspection of the funnel plot suggested some asymmetry, but Egger’s regression test did not reach statistical significance, offering no clear evidence of small-study effects. Risk of bias was assessed with the Joanna Briggs Institute critical appraisal checklist for cohort studies, and all included studies were rated as low to medium risk.

Why do children with disabilities die more often? The authors outline three interacting pathways. The first is social: children with disabilities are disproportionately exposed to poverty, limited education, inadequate housing, stigma, social isolation, violence and abuse—all of which erode health. The second is biological: the underlying impairment itself can amplify risk, as with the elevated rates of leukaemia and congenital heart defects seen in Down syndrome. The third is systemic: inaccessible facilities, negative provider attitudes, and insufficient training among health professionals create barriers to quality care, from routine vaccination to emergency treatment.

Crucially, the diversity of impairments included in the review suggests the elevated mortality cannot be explained by impairment alone. Evidence from cause-specific studies points to many deaths from common, preventable conditions such as pneumonia and other infectious and respiratory diseases, alongside deaths from injuries, poisoning, nervous system diseases and suicide. The UK Confidential Inquiry into premature deaths of people with intellectual disabilities previously identified high proportions of avoidable deaths linked to delayed diagnosis and inequities in the quality of care—findings that resonate with the global pattern now documented in children.

The review also exposes deep gaps in the evidence base itself. Nearly all included studies came from high-income countries, with 16 of 29 from Europe alone; four WHO regions were represented but South-East Asia and the Eastern Mediterranean were entirely absent. Most studies relied on administrative or medical records, meaning children whose disabilities are never clinically identified or recorded were likely missed. Sex-disaggregated data were unavailable in most studies, and there was too little information to analyse mortality by cause, disability severity, or world region. With roughly 240 million children with disabilities worldwide—the majority living in low- and middle-income countries—the absence of data from precisely the settings where the burden is greatest is itself a finding.

The authors call for disability to be embedded in routine health policy, planning and financing, for strengthened primary healthcare with clear pathways between community services, rehabilitation and specialised paediatric care, and for investment in accessible facilities, assistive technology and communication supports. They also urge researchers to adopt standardised measures such as the Washington Group questions, to link disability identifiers into demographic surveillance and mortality databases, and to investigate which deaths are avoidable. What is needed now, the review concludes, is not simply more documentation of the gap, but rigorous evidence on what actually works to close it.

Subject of Research: The association between disability and all-cause mortality among children and adolescents worldwide

Article Title: The association between disability and mortality among children and adolescents: A systematic review and meta-analysis

Article References: Moyo-Chilufya, M., Nguweneza, A., Rotenberg, S., Kuper, H., & Smythe, T. (2026). The association between disability and mortality among children and adolescents: A systematic review and meta-analysis. PLOS Medicine, 23(9), e1004947. https://doi.org/10.1371/journal.pmed.1004947

Image Credits: AI Generated

DOI: 10.1371/journal.pmed.1004947

Keywords: disability, child mortality, adolescent health, meta-analysis, systematic review, health equity, neurological disability, intellectual disability, global health, PLOS Medicine, health systems, pediatrics

The distinction the authors draw at the outset is technically important. Health inequality describes any uneven distribution of health outcomes; health inequity refers specifically to inequalities that arise from unjust, and therefore remediable, social structures. Most child health inequalities, they contend, fall into the second category, rooted in the unequal distribution of social determinants such as education, employment, healthcare, and life opportunities. Children are uniquely exposed to these forces because they are physiologically immature, immunologically underdeveloped, and entirely dependent on caregivers and health systems to meet their needs. Early malnutrition and infection can directly impair cognitive development and set lifelong health trajectories, meaning that disadvantage in childhood propagates forward into reduced educational attainment, lower workforce productivity, and ultimately a self-perpetuating cycle of social inequality across generations.

The editorial’s central analytical move is to frame healthcare access as the mediating bridge between social inequality and child health. Drawing on the widely used four-dimension model, the authors decompose access into availability, accessibility, affordability, and acceptability. In many low- and middle-income settings, all four are compromised simultaneously. On the demand side, low insurance coverage, inadequate financial protection, cultural beliefs, limited health literacy, and distrust of health systems make it difficult for families to seek and afford care. On the supply side, shortages of facilities, outdated equipment, and insufficient medicine stocks prevent even basic services from meeting population needs. Paradoxically, in some countries that have expanded public primary healthcare infrastructure, many facilities remain underutilized while children continue to face substantial difficulty obtaining care, a signal that building clinics alone does not guarantee access.

The mechanistic chain is well documented. Prenatal care, place of delivery, care-seeking behavior, and the use of maternal and child health services are among the strongest determinants of survival in the under-fives. Where facilities are inadequate or costs are prohibitive, diagnosis and treatment are delayed, and the risk of mortality rises directly. Preterm birth, lower respiratory infections, and birth asphyxia or birth trauma are now the three leading causes of under-five death worldwide, with malaria, diarrhea, and pneumonia still claiming large numbers of lives, and the vast majority of these deaths are preventable with timely treatment. It is precisely through the erosion of access that socioeconomic disadvantage, low parental education, and urban-rural development gaps are converted into disparities in health outcomes. The problem, in short, is seldom a shortage of effective interventions; it is the profound inequity of who can reach them.

Crucially, the relative weight of the four barrier dimensions differs sharply by region, and the authors argue this variation has been neglected in the literature. In sub-Saharan Africa, geographical accessibility and shortages of health workers are the most urgent constraints, whereas in parts of South Asia, sociocultural obstacles such as women’s limited autonomy in healthcare decisions may matter more than economic ones. No single intervention is therefore likely to work everywhere. They propose a dynamic, country- and region-level assessment system that weights the four barrier dimensions, identifies priorities, and supports modular intervention packages that each country can assemble according to its own barrier profile. Real-time data monitoring and AI-supported decision tools would allow priorities to be adjusted continuously, while community engagement and task sharing would strengthen local responsiveness, moving strategy away from one-size-fits-all models toward precisely tailored approaches.

Beneath these operational barriers lie structural drivers operating at three levels. At the macro level, low- and middle-income countries frequently cannot channel adequate public funding into health, producing chronic shortages of pediatric specialists, essential medicines, and equipment, with the scarce resources that exist concentrated in urban and prosperous areas. At the mid level, primary care facilities are often unable to perform essential functions such as screening, early diagnosis, and continuous management, and weak referral and health information systems undermine continuity of care. At the micro level, low-income households cannot afford the costs of childhood illness, which delays treatment and damages household economic well-being in a vicious cycle, while hunger and poverty produce stunting, cognitive deficits, and low educational attainment that both raise disease risk and restrict access to care. These factors act cumulatively: macro-level misallocation weakens system capacity, which magnifies micro-level socioeconomic barriers. Subsidizing household costs without ensuring that clinics can actually diagnose and treat, the authors warn, will significantly blunt the impact of such spending.

The vulnerability of children gives these mechanisms their particular ferocity. An estimated 250 million children under five in low- and middle-income countries are at risk of failing to reach their full developmental potential, a deficit with lasting repercussions for schooling, employment, and social functioning. The effects are not linear but cumulative across multiple pathways: malnutrition raises infection risk directly while also impairing immunological memory and cognitive development, reducing adult productivity and health literacy and exposing the next generation to the same risks. This intergenerational transmission makes the window for intervention extraordinarily narrow. Once the first 1000 days of life are missed, the cost of compensatory interventions multiplies while their effectiveness declines substantially. The editorial therefore calls for a continuous support package from preconception to age two, integrating maternal nutritional supplementation, infant vaccination, infection management, early cognitive stimulation, and parenting guidance, backed by a proactive risk surveillance system that uses primary care data and socioeconomic indicators, such as low maternal education and household food insecurity, to trigger targeted home visits and nutritional support.

On policy, the authors propose a tiered timeline rather than piecemeal projects. In the short term, one to two years, governments should waive medical fees for at least five common fatal childhood conditions, pneumonia, diarrhea, malaria, neonatal asphyxia, and preterm birth complications, so that impoverished children receive free care at public facilities, and should deploy community emergency funds and mobile medical teams in remote areas. In the medium term, three to five years, the focus shifts to primary care capacity: regional pediatric service gap maps to target underserved areas, and expanded training so community health workers and primary care doctors can manage pediatric emergencies, including neonatal resuscitation, pulse oximetry for pneumonia, and oral rehydration therapy for diarrhea. In the long term, five to ten years, structural reform is required, embedding child health equity indicators such as a child healthcare access index and the urban-rural under-five mortality ratio into national budget performance assessments, overseen by an intersectoral committee spanning health, education, finance, social security, and nutrition.

Digital health features prominently in the framework, but with a cautionary edge. Telemedicine and artificial intelligence can, in principle, overcome geographic barriers and extend specialist expertise to areas with limited transport, yet implementation in low- and middle-income countries confronts unstable power grids, limited network coverage, low digital literacy among clinicians and patients, and weak local capacity for equipment maintenance. The authors advocate a hybrid strategy: pilot digital solutions where infrastructure is relatively robust while simultaneously preserving and strengthening community-based primary care networks, avoiding the trap of prioritizing technology over foundational system capacity. For poorly connected regions, home visits by community health workers with standardized diagnostic protocols remain the most practical near-term option. They also stress that health interventions alone are insufficient, and must be complemented by income redistribution, tax reform, and functioning social security systems that narrow the broader societal income gap.

The editorial closes with a challenge to the international community: recognize reducing disparities in children’s access to healthcare as an independent, measurable core indicator of global health progress. Four quantifiable priorities anchor the call, directing at least 60 percent of public child health spending to primary care and rural areas, guaranteeing full fee exemptions and a child-specific health safety net independent of general insurance, equipping every primary care facility with essential pediatric diagnostic and emergency capabilities, and embedding child health equity indicators into ministerial performance reviews with annual public disclosure and independent third-party audits. Experiences in countries such as Zambia and Bangladesh demonstrate that even under severe resource constraints, political commitment and community mobilization can narrow child health gaps within a relatively short timeframe. Child health inequalities, the authors insist, are not inevitable; they are reflections of societal choices, and every preventable child death is a test of both conscience and institutional justice that the world can no longer defer.

Subject of Research: Barriers to healthcare access and child health equity in low- and middle-income countries

Article Title: Health equity begins with children: dismantling barriers to healthcare access in low- and middle-income countries

Article References: Ou, L.-Y., Zhang, Y., & Zhang, Y.-T. (2026). Health equity begins with children: dismantling barriers to healthcare access in low- and middle-income countries. World Journal of Pediatrics. https://doi.org/10.1007/s12519-026-01100-y

Image Credits: AI Generated

DOI: 10.1007/s12519-026-01100-y

Keywords: child mortality, health equity, healthcare access, low- and middle-income countries, malnutrition, first 1000 days, primary care, universal health coverage, digital health, social determinants of health, pediatrics, global health